TSFG, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
TSFG, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$435
-26.4%
28,115
-25.3%
0.16%
-29.5%
Q2 2023$591
-6.2%
37,647
-1.5%
0.22%
-6.0%
Q1 2023$630
+7.5%
38,235
+1.8%
0.23%
+0.4%
Q4 2022$586
-99.9%
37,570
-0.3%
0.23%
+1.7%
Q3 2022$489,000
-1.2%
37,695
+7.0%
0.23%
+7.5%
Q2 2022$495,000
-2.0%
35,2370.0%0.21%
+16.4%
Q1 2022$505,000
-5.6%
35,237
-10.3%
0.18%
-1.6%
Q4 2021$535,000
-19.7%
39,273
-3.4%
0.19%
-28.5%
Q3 2021$666,000
-9.3%
40,644
-6.8%
0.26%
-12.2%
Q2 2021$734,000
-10.4%
43,607
-2.8%
0.30%
-28.8%
Q1 2021$819,000
-4.3%
44,844
-4.7%
0.42%
-9.0%
Q4 2020$856,000
-1.9%
47,056
-3.9%
0.46%
-11.9%
Q3 2020$873,000
-0.6%
48,947
-0.1%
0.52%
-10.5%
Q2 2020$878,000
+19.1%
48,976
+0.9%
0.58%
-11.9%
Q1 2020$737,000
-22.7%
48,523
+0.3%
0.66%
-6.9%
Q4 2019$954,000
+14.8%
48,368
+0.1%
0.71%
+11.2%
Q3 2019$831,000
-2.7%
48,299
+0.1%
0.64%
-7.3%
Q2 2019$854,000
-12.3%
48,254
+1.0%
0.69%
-17.2%
Q1 2019$974,00047,7950.83%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders